Paul Aubert's most recent trade in Bio-Path Holdings Inc was a trade of 2,000 Common Stock Option (right to buy) done . Disclosure was reported to the exchange on July 30, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bio-Path Holdings Inc | Paul D. Aubert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2024 | 2,000 | 2,000 | - | - | Common Stock Option (right to buy) | |
| Bio-Path Holdings Inc | Paul Aubert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 10,000 | 10,000 | - | - | Common Stock Option (right to buy) | |
| Bio-Path Holdings Inc | Paul Aubert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2022 | 10,000 | 10,000 | - | - | Common Stock Option (right to buy) |